Investigated for use/treatment in obesity.

Investigated for use/treatment in asthma.

Investigated for use/treatment in insomnia.

Investigated for use/treatment in adverse effects (drug), hyperlipidemia, and obesity.

Investigated for use/treatment in psoriasis and psoriatic disorders and skin infections/disorders.

Investigated for use/treatment in growth hormone deficiencies/abnormalities.

Investigated for use/treatment in HIV infection.

Investigated for use/treatment in osteoporosis.

Investigated for use/treatment in pediatric indications and seizure disorders.

Investigated for use/treatment in liver disease and pulmonary fibrosis.

Investigated for use/treatment in prostate cancer.

Investigated for use/treatment in amyotrophic lateral sclerosis (ALS) and parkinson's disease.

Vasopressin regulates renal water resorption through the V2 receptor. Inhibition of vasopressin’s effects on V2 receptors enhances water excretion and increases urinary output. ...

Investigated for use/treatment in multiple sclerosis.

Investigated for use/treatment in cardiovascular disorders and strokes.

Investigated for use/treatment in prostate cancer.

Investigated for use/treatment in depression.

Investigated for use/treatment in psychosis and schizophrenia and schizoaffective disorders.

Labetuzumab is a humanized monoclonal antibody used to treat cancer. Retrieved from "http://en.wikipedia.org/wiki/Labetuzumab"

Investigated for use/treatment in lipodystrophy and obesity.